Literature DB >> 11721494

[Whipple disease associated with pulmonary arterial hypertension. Jarisch-Herxheimer reaction after antibiotic therapy].

S Peschard1, A Brinkane, S Bergheul, L Crickx, B Gaudin, M Morcelet, R Levy.   

Abstract

BACKGROUND: Pulmonary hypertension is an uncommon feature of Whipple's disease and the underlying pathophysiological mechanism remains a subject of debate. CASE REPORT: A 57-year-old woman was hospitalized for exploration of migrating joint pain that had developed for 5 years. Histologically proven Whipple's disease was diagnosed on duodenal biopsies. The lung angiogram performed to explore signs of right heart failure demonstrated pulmonary hypertension and ruled out pulmonary embolism. Abundant pericardial effusion developed progressively. Antibiotic therapy using sulfamethoxazole-trimethoprime led to a systemic Jarisch Herxheilmer reaction. The pulmonary hypertension resolved rapidly, the pericardial effusion more slowly. DISCUSSION: The pulmonary hypertension in this patient appeared to be directly related to Whipple's disease, probably via vascular infiltration by Tropheryma whippeli.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11721494

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  Whipple's disease-associated pulmonary hypertension with positive vasodilator response despite severe hemodynamic derangements.

Authors:  Salah Najm; Joud Hajjar; Robert P Nelson; Ramana S Moorthy; Karen M Wolf; Tim Lahm
Journal:  Can Respir J       Date:  2011 Sep-Oct       Impact factor: 2.409

2.  Reversible pulmonary hypertension in Whipple disease: a case report with clinicopathological implications, and literature review.

Authors:  Pamela L Lyle; Robert D Weber; Javier Bogarin; Tobias Kircher
Journal:  BMJ Case Rep       Date:  2009-05-13

3.  Reversible Pulmonary Hypertension Associated with Whipple's Disease.

Authors:  A Villa; G Nucera; A Kostihova; A Mazzola; P Marino
Journal:  Case Rep Pulmonol       Date:  2012-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.